PeptideDB

3-Hydroxyvaleric acid 10237-77-1

3-Hydroxyvaleric acid 10237-77-1

CAS No.: 10237-77-1

3-Hydroxyvaleric acid is a five-carbon ketone body. 3-Hydroxyvaleric acid could undergo anaplerotic reaction, that is, i
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

3-Hydroxyvaleric acid is a five-carbon ketone body. 3-Hydroxyvaleric acid could undergo anaplerotic reaction, that is, it can replenish the intermediate products of the tricarboxylic acid cycle.

Physicochemical Properties


Molecular Formula C5H10O3
Exact Mass 118.063
CAS # 10237-77-1
Related CAS # 83120-66-5
PubChem CID 107802
Appearance Off-white to light yellow <43°C solid powder,>44°C liquid
Density 1.14g/cm3
Boiling Point 253.3ºC at 760mmHg
Flash Point 121.2ºC
Vapour Pressure 0.00285mmHg at 25°C
Index of Refraction 1.458
LogP 0.232
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 3
Heavy Atom Count 8
Complexity 79.7
Defined Atom Stereocenter Count 0
SMILES

CCC(O)CC(O)=O

InChi Key REKYPYSUBKSCAT-UHFFFAOYSA-N
InChi Code

InChI=1S/C5H10O3/c1-2-4(6)3-5(7)8/h4,6H,2-3H2,1H3,(H,7,8)
Chemical Name

3-hydroxypentanoic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Additional Infomation 3-hydroxypentanoic acid is a short-chain fatty acid that is valeric acid in which one of the methylene hydrogens at position 3 has been replaced by a hydroxy group. It is a short-chain fatty acid, a 3-hydroxy fatty acid and a ketone body. It is functionally related to a valeric acid.
3-Hydroxypentanoic acid has been reported in Brassica napus and Carteriospongia with data available.

Solubility Data


Solubility (In Vitro) DMSO : ≥ 100 mg/mL (~846.53 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (21.16 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (21.16 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (21.16 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)